Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > News > Advance Care Planning increases hope
  • News

Advance Care Planning increases hope

  • 18 June 2021
  • Janet Fricker
Advance Care Planning increases hope
Total
1
Shares
1
0
0
0
0

Hope for cancer patients may be increased by engaging in advanced care planning (ACP). The study, abstract 12029, presented in a poster session at ASCO, which took place online June 4-8, found that hope was significantly higher among patients who had engaged in end-of-life (EOL) conversations and completed a living will or advance directive.

“Hope is an important aspect of taking care of patients at the end of life. Multiple research studies show it’s really important, with many patients, suggesting hope has helped mitigate their anxiety and depression, and other studies suggesting it may even benefit symptoms,” said study presenter Michael Cohen, from the University of Pittsburgh, Pennsylvania. But fear of patients ‘giving up hope’ is one of the principal reasons oncologists cite for deferring the offer of advance care planning to cancer patients until late in the course of disease. With research lacking about the relationship between ACP and hope, Cohen and colleagues set out to determine how ACP in the form of an end-of-life conversation with an oncologist or completion of a living will/advance directive was associated with patient hope.

The current research  was a secondary analysis of longitudinal data from the Connect study exploring palliative interventions in patients with advanced solid tumours, for whom providers ‘would not be surprised if they died within the next year’, and ECOG performance status 0-2. In a validated questionnaire, patients were asked whether providers had talked to them about the care they would want to receive if they were dying, and whether they had completed a living will/advance directive.

Levels of hope were measured using the Herth Hope Index (HHI), a scale ranging from 12 to 48, with higher scores indicating higher levels of hope. “It measures the state as opposed to trait of hope, measuring hope at any one time, not how hopeful the individual person is as part of their personality,” explained Cohen. Additionally, multivariate regression was performed to control for baseline HHI scores, study randomisation and age, religious importance, education, marital status, socioeconomic status, time since cancer diagnosis, pain/symptom burden, and anxiety/ depression scores.

Altogether, 672 patients were recruited (mean age of 69±10), with the most common cancer types being lung (36%), gastrointestinal (20%), and breast/ gynaecologic (16%). Of 378 participants (56% of study population) who had not undergone an EOL conversation at baseline, 111 (29%) went on to report having had one by three months. Additionally, of 216 (32%) of patients without an advance directive at baseline, 67 (31%) had completed one by three months.
At three months the preliminary analysis found no difference between patients who had and those who had not had an EOL conversation (P=0.707) or between patients who had and those who had not completed a living will/advance directive (P=0.134). However, after multivariable adjustment, there were significant increases in ‘hope’ among patients who had engaged in the EOL conversations compared to those who had not (P=0.032) and among patients who had completed a living will/ advance directive compared to those who had not (P=0.030).

“Overall, we believe the results of this study will enable providers to feel more comfortable having these important conversations about advance care planning with their patients, without  fear of giving up hope,” says Cohen. With study participants representing a fairly homogenous racial population and end-of-life preferences differing according to cultural backgrounds, he added, it will be important to repeat the study with different cultural groups.
Limitations include the study being a secondary analysis of another randomised controlled trial, with the result the analysis cannot show causation, only association.

Total
1
Shares
Share 1
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • Advance care planning
  • advance directive
  • end of life conversations
  • herth hope index
  • hope
  • living will
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • Obituaries

Angelo Di Leo leaves a living legacy of quality care and research excellence

  • 14 June 2021
  • Anna Wagstaff
View Post
Next Article
  • News

ACE inhibitor protects against cardiotoxicity

  • 18 June 2021
  • Janet Fricker
View Post
You May Also Like
View Post
  • News

Study highlights need to reanalyse genomics and genetics of metastatic tumours

  • Janet Fricker
  • 27 January 2023
View Post
  • News

Current cervical cancer screening paradigm fails older women

  • Janet Fricker
  • 26 January 2023
View Post
  • News

Call-to-arms for Europe to provide essential paediatric anti-cancer medicines

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Exercise-stimulated myokine production can extend survival in advanced prostate cancer

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Five San Antonio take-aways to improve care of breast cancer patients

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Repurposed drug combination reduces risk of recurrence following surgery for colorectal cancer

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Aerobic activity to outcompete metastasis 

  • Janet Fricker
  • 2 December 2022
View Post
  • News

Ending cancer inequalities: European summit showcases new tools to inform policy

  • Anna Wagstaff
  • 30 November 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Study highlights need to reanalyse genomics and genetics of metastatic tumours
    • 27 January 2023
  • Current cervical cancer screening paradigm fails older women
    • 26 January 2023
  • Call-to-arms for Europe to provide essential paediatric anti-cancer medicines
    • 9 January 2023
  • Exercise-stimulated myokine production can extend survival in advanced prostate cancer
    • 9 January 2023
  • Five San Antonio take-aways to improve care of breast cancer patients
    • 16 December 2022
Article
  • The cancer patients still struggling to access drugs in the wake of anti-corruption reforms
    • 27 January 2023
  • Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
    • 26 January 2023
  • Cervical cancer elimination efforts boosted by simpler ways to identify and treat pre-cancerous lesions
    • 12 January 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • Hansjörg Senn of St Gallen: A practice-changing career
    • 3 February 2023
  • AI in Genomics and Reporting for Clinical Practice
    • 26 January 2023
  • Telemedicine in Cancer Care: Monitoring, Follow-Up,Tele-Rehabilitation, Palliative and Supportive Care
    • 23 January 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.